Novo Nordisk and Eli Lilly Address Weight Loss Drug Supply Issues
Good afternoon! All eyes are once again on Novo Nordisk and Eli Lilly as Wall Street looks for signs they…
health care industry
Eli Lilly's Weight Loss Drug May Treat Fatty Liver Disease
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
Why Wall Street Analysts Think Big Tech Stocks Will Take a Breath
Every weekday, the CNBC Investing Club with Jim Cramer hosts a livestream of the “morning meeting” at 10:20 a.m. ET.…
Eli Lilly (LLY) Q4 2023 Earnings
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, U.S., on September 17,…
King Charles diagnosed with cancer
Britain's King Charles leaves the London Clinic after receiving treatment for an enlarged prostate in London, Britain, on January 29,…
Novo Nordisk's parent company will buy Catalent to expand Wegovy supply
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
J&J, Merck and Bristol Myers Squibb on the bench
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Good afternoon!…
Non-opioid pain reliever Vertex shows positive results in late-stage trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston on Oct. 23, 2019. Brian Snyder | Reuters…
GSK sees huge RSV vaccine sales, raises outlook
The logo of pharmaceutical company GlaxoSmithKline is seen at its facility in Stevenage, Britain, October 26, 2020. Ruvic Dice |…
Biogen abandons Alzheimer's drug Aduhelm to focus on Leqembi, others
Biogen headquarters in Cambridge, Massachusetts, on October 24, 2023. vanessa leroy | Bloomberg | fake images biogen on Wednesday said…